These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36132130)
21. Development and validation of a novel fibroblast scoring model for lung adenocarcinoma. Wei S; Gu X; Zhang W Front Oncol; 2022; 12():905212. PubMed ID: 36072807 [TBL] [Abstract][Full Text] [Related]
22. Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model. Nie S; Huili Y; He Y; Hu J; Kang S; Cao F Front Surg; 2022; 9():860857. PubMed ID: 35478725 [TBL] [Abstract][Full Text] [Related]
23. An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer. Shi H; Peng Q; Zhou X; He Y; Sun S Front Genet; 2022; 13():848747. PubMed ID: 35419022 [TBL] [Abstract][Full Text] [Related]
24. Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer. He R; Zhang M; He L; Huang J; Man C; Wang X; Lang Y; Fan Y Front Med (Lausanne); 2022; 9():845271. PubMed ID: 35479956 [TBL] [Abstract][Full Text] [Related]
25. Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma. Wu Z; Huang X; Cai M; Huang P; Guan Z Aging (Albany NY); 2022 Jan; 14(2):869-891. PubMed ID: 35077391 [TBL] [Abstract][Full Text] [Related]
26. A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer. Zhang X; Zhang X; Li G; Hao Y; Liu L; Zhang L; Chen Y; Wu J; Wang X; Yang S; Xu S J Immunol Res; 2022; 2022():3143511. PubMed ID: 35578667 [TBL] [Abstract][Full Text] [Related]
27. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma. Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755 [TBL] [Abstract][Full Text] [Related]
28. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer. Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y Front Immunol; 2022; 13():894718. PubMed ID: 35812403 [TBL] [Abstract][Full Text] [Related]
29. A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes. Qiu Q; Li Y; Zhang Y; Hou Y; Hu J; Wang L; Chen Z; Lei Y; Du Y; Liu X Front Med (Lausanne); 2022; 9():942991. PubMed ID: 36016998 [TBL] [Abstract][Full Text] [Related]
30. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma. Fu X; Yang Y; Zhang X Front Genet; 2022; 13():919599. PubMed ID: 36134033 [No Abstract] [Full Text] [Related]
31. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas. Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z Front Immunol; 2022; 13():877815. PubMed ID: 35663937 [TBL] [Abstract][Full Text] [Related]
32. A Novel Signature of Necroptosis-Associated Genes as a Potential Prognostic Tool for Head and Neck Squamous Cell Carcinoma. Huang J; Huo H; Lu R Front Genet; 2022; 13():907985. PubMed ID: 35754840 [No Abstract] [Full Text] [Related]
33. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma. Zhang Q; Zhu Z; Guan J; Zheng C Front Oncol; 2022; 12():904614. PubMed ID: 35814424 [TBL] [Abstract][Full Text] [Related]
34. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy. Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S Front Genet; 2021; 12():790888. PubMed ID: 34976022 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432 [TBL] [Abstract][Full Text] [Related]
36. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
37. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B Front Oncol; 2022; 12():915662. PubMed ID: 36033441 [TBL] [Abstract][Full Text] [Related]
38. The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas. Ba Y; Su J; Gao S; Liao Z; Wu Z; Cao C; Liang C; Gong J; Guo Y Front Oncol; 2022; 12():899443. PubMed ID: 35756610 [TBL] [Abstract][Full Text] [Related]
39. Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer. Xie J; Tian W; Tang Y; Zou Y; Zheng S; Wu L; Zeng Y; Wu S; Xie X; Xie X Front Mol Biosci; 2022; 9():834593. PubMed ID: 35601830 [No Abstract] [Full Text] [Related]
40. Necroptosis is Related to Anti-PD-1 Treatment Response and Influences the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. Wang Q; Wang F; Zhao Y; Tan G Front Genet; 2022; 13():862143. PubMed ID: 35692819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]